skip to main content

We are fortunate to advise world-class, industry-leading companies, helping them tackle novel, complex issues and push the boundaries of technological progress. Our ability and confidence to go to trial is our core strength; our deep bench of experienced trial lawyers represents companies in their most significant matters, helping them protect their intellectual property and launch products. Our lawyers pair extensive experience in the courtroom and the boardroom with a thorough understanding of science and technology.

Andrew Finch and Stefan Geirhofer Publish Competition Policy International Article on Procompetitive Collaborations in the Life Sciences

April 9, 2021

Litigation partner Andrew Finch and associate Stefan Geirhofer co-wrote an article, “Features of Procompetitive Collaborations in the Life Sciences,” published in Competition Policy International’s Intellectual Property column. The authors highlight a recent joint workshop hosted by the U.S. Department of Justice and the U.S. Patent and Trademark Office that discussed the procompetitive role of collaborations in today’s innovation economy, specifically in the life sciences and technology sectors. Andrew and Stefan emphasize that collaborations play an important procompetitive role—especially in the case of the COVID-19 pandemic, where collaborative research sped up the quest for treatment and allowed the vaccine to arrive on the market faster—so long as their structural and scope limitations, along with information-sharing safeguards, can effectively limit anticompetitive risks.

» read the article

© 2021 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy